Researchers from Northwestern University developed an easy-to-calculate, four-factor score which identified 92.2 percent of true strokes among 330 inpatients who triggered stroke alerts.

Evolocumab appears to be equally effective at reducing LDL cholesterol and preventing cardiovascular events regardless of a patient’s kidney function, according to a new subanalysis of the FOURIER outcomes study presented at the American Society of Nephrology’s annual Kidney Week in San Diego.

Patricia V. Blake will take over as CEO of the Heart Rhythm Society (HRS) next March, HRS leadership announced Oct. 26.

Omega-3 treatment was associated with significantly fewer gastrointestinal bleeding events for patients with left ventricular assist devices (LVADs), researchers reported in Circulation: Heart Failure.

The majority of ST-segment elevation myocardial infarction (STEMI) patients in the Midwest live within an hour of their nearest percutaneous coronary intervention (PCI)-capable hospital and are able to undergo primary PCI within two hours of an MI, researchers reported in the American Journal of Cardiology.

Colder temperatures, stronger winds and fewer hours of sunlight could all raise a person’s risk of myocardial infarction, researchers reported in JAMA Cardiology.

Higher ejection fractions (EFs) among heart failure patients are associated with an increased incidence of atrial fibrillation (AF) and worse cardiovascular outcomes, according to data from a multinational European registry.

Overweight and obese women might face better odds against diabetes, insulin resistance and CVD than men, according to a rodent study out of York University in Toronto.